Comparison of the permeability of metoprolol and labetalol in rat, mouse, and caco-2 cells: Use as a reference standard for BCS classification

Molecular Pharmaceutics

Volumn 10, Issue 3, 2013, Pages 958-966

  Incecayir, Tuba ^a,b   Tsume, Yasuhiro ^a   Amidon, Gordon L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Biopharmaceutics Classification Systems (BCS); Caco 2; labetalol; metoprolol; permeability; reference standard; single pass intestinal perfusion

Indexed keywords

LABETALOL; METOPROLOL; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL STRAIN CACO 2; DRUG PENETRATION; ILEUM; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; INTESTINE PERFUSION; JEJUNUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84874608792     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300410n     Document Type: Article

References (51)

1. U.S. Food and Drug Administration, Center for Drug Evaluationand Research (CDER). Guidance for Industry: Bioavailability and BioequivalenceStudies for Orally Administered Drug Products-General Considerations,March (2003; Division of Drug Information Branch, HFD-240, Center for Drug Evaluation and Research, FDA: Rockville, MD; http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM070124.pdf.
2. European Medicines Agency (EMEA) Committeefor MedicinalProducts for Human Use. Guideline on the Investigation of Bioequivalence;Doc.Ref.: CPMP/EWP/QWP/1401/98Rev.1/Corr; EMEA: London, January 20, 2010; http://www.emea.europa.eu/docs/en-GB/document-library/Scientific-guideline/2010/ 01/WC500070039.pdf.
3. Amidon, G. L.; Lennernäs, H.; Shah, V. P.; Crison, J. R. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability Pharm. Res. 1995, 12, 413-420
4. Polli, J. E.; Abrahamsson, B. S. I.; Yu, L. X.; Amidon, G. L.; Baldoni, J. M.; Cook, J. A.; Fackler, P.; Hartauer, K.; Johnston, G.; Krill, S. L.; Lipper, R. A.; Malick, W. A.; Shah, V. P.; Sun, D.; Winkle, H. N.; Wu, Y.; Zhang, H. Summary Workshop Report: Bioequivalence, Biopharmaceutics Classification System, and Beyond AAPS J. 2008, 10, 373-379
5. Chen, M.-L.; Amidon, G. L.; Benet, L. Z.; Lennernas, H.; Yu, L. X. The BCS, BDDCS, and Regulatory Guidances Pharm. Res. 2011, 28, 1774-1778
6. U.S. Food and Drug Administration, Center for Drug Evaluationand Research (CDER). Guidance for Industry: Waiver of In Vivo Bioavailabilityand Bioequivalence Studies for Immediate-Release Solid Oral DosageForms Based on a Biopharmaceutics Classification System, August (2000; http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070246.pdf.
7. Cook, J.; Addicks, W.; Wu, Y. H. Application of the Biopharmaceutical Classification System in Clinical Drug Development-An Industrial View AAPS J. 2008, 10, 306-310
8. Ku, M. S. Use of the Biopharmaceutical Classification System in Early Drug Development AAPS J. 2008, 10, 208-212
9. Lennernäs, H.; Abrahamsson, B. The Use of Biopharmaceutic Classification of Drugs in Drug Discovery and Development: Current Status and Future Extension J. Pharm. Pharmacol. 2005, 57, 273-285
10. Cao, X.; Gibbs, S. T.; Fang, L.; Miller, H. A.; Landowski, C. P.; Shin, H.-C.; Lennernas, H.; Zhong, Y.; Amidon, G. L.; Yu, L. X.; Sun, D. Why is it Challenging to Predict Intestinal Drug Absorption and Oral Bioavailability in Human Using Rat Model Pharm. Res. 2006, 23, 1675-1686
11. Dahan, A.; Miller, J. M.; Hilfinger, J. M.; Yamashita, S.; Yu, L. X.; Lennernäs, H.; Amidon, G. L. High-Permeability Criterion for BCS Classification: Segmental/pH Dependent Permeability Considerations Mol. Pharmaceutics 2010, 7, 1827-1834
12. Dahan, A.; Amidon, G. L. Grapefruit Juice and its Constituents Augment Colchicine Intestinal Absorption: Potential Hazardous Interaction and the Role of P-Glycoprotein Pharm. Res. 2009, 26, 883-892
13. Volpe, D. A. Drug-Permeability and Transporter Assays in Caco-2 and MDCK Cell Lines Future Med. Chem. 2011, 3, 2063-2077
14. Hubatsch, I.; Ragnarsson, E. G.; Artursson, P. Determination of Drug Permeability and Prediction of Drug Absorption in Caco-2 Monolayers Nat. Protocols 2007, 2, 2111-2119
15. Kim, J.-S.; Mitchell, S.; Kijek, P.; Tsume, Y.; Hilfinger, J.; Amidon, G. L. The Suitability of an in Situ Perfusion Model for Permeability Determinations: Utility for BCS Class I Biowaiver Requests Mol. Pharmaceutics 2006, 3, 686-694
16. Dahan, A.; Amidon, G. L. Segmental Dependent Transport of Low Permeability Compounds along the Small Intestine Due to P-Glycoprotein: The Role of Efflux Transport in the Oral Absorption of BCS Class III Drugs Mol. Pharmaceutics 2008, 6, 19-28
17. 1-Receptor Antagonist Metoprolol in Man J. Pharmacokinet. Biopharm. 1974, 2, 347-364
18. Volpe, D. A. Permeability Classification of Representative Fluoroquinolones by a Cell Culture Method AAPS Pharm. Sci. 2004, 6, 1-6
19. Volpe, D. A.; Faustino, P. J.; Ciavarella, A. B.; Asafu-Adjaye, E. B.; Ellison, C. D.; Yu, L. X.; Hussain, A. S. Classification of Drug Permeability with a Caco-2 Cell Monolayer Assay Clin. Res. Reg. Affairs 2007, 24, 39-47
20. Thiel-Demby, V. E.; Humphreys, J. E.; St. John Williams, L. A.; Ellens, H. M.; Shah, N.; Ayrton, A. D.; Polli, J. W. Biopharmaceutics Classification System: Validation and Learnings of an in Vitro Permeability Assay Mol. Pharmaceutics 2008, 6, 11-18
21. Jappar, D.; Wu, S.-P.; Hu, Y.; Smith, D. E. Significance and Regional Dependency of Peptide Transporter (PEPT) 1 in the Intestinal Permeability of Glycylsarcosine: In Situ Single-Pass Perfusion Studies in Wild-Type and Pept1 Knockout Mice Drug. Metab. Dispos. 2010, 38, 1740-1746
22. Fagerholm, U.; Johansson, M.; Lennarnäs, H. Comparison Between Permeability Coefficients in Rat and Human Jejunum Pharm. Res. 1996, 13, 1336-1342
23. Meier, J. Pharmacokinetic Comparison of Pindolol with Other Beta-Adrenoceptor-Blocking Agents Am. Heart J. 1982, 104, 364-373
24. Jobin, G.; Cortot, A.; Godbillon, J.; Duval, M.; Schoeller, J. P.; Hirtz, J.; Bernier, J. J. Investigation of Drug Absorption From the Gastrointestinal Tract of Man. I. Metoprolol in the Stomach, Duodenum and Jejunum Br. J. Clin. Pharmacol. 1985, 19, 97S-105S
25. Vidon, N.; Evard, D.; Godbillon, J.; Rongier, M.; Duval, M.; Schoeller, J. P.; Bernier, J. J.; Hirtz, J. Investigation of Drug Absorption From the Gastrointestinal Tract of Man. II. Metoprolol in the Jejunum and Ileum Br. J. Clin. Pharmacol. 1985, 19, 107S-112S
26. Martin, L. E.; Hopkins, R.; Bland, R. Metabolism of Labetalol by Animals and Man Br. J. Clin. Pharmacol. 1976, 3, 695-710
27. McNeil, J. J.; Anderson, A. E.; Louis, W. J.; Morgan, D. J. Pharmacokinetics and Pharmacodynamic Studies of Labetalol in Hypertensive Subjects Br. J. Clin. Pharmacol. 1979, 8, 157S-161S
28. Fujimura, A.; Ohashi, K.; Tsuru, M.; Ebihara, A.; Kondo, K. Clinical Pharmacology of Dilevalol (I). Comparison of the Pharmacokinetic and Pharmacodynamic Properties of Dilevalol and Labetalol After a Single Oral Administration in Healthy Subjects J. Clin. Pharmacol. 1989, 29, 635-642
29. Hoffman, B. B. Catecholamines, Sympathomimetic Drugs, and Adrenergic Receptor Antagonists. In The Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10 th ed.; Hardman, J. G.; Limbird, L. E.; Gilman, A. G., Eds.; McGraw-Hill Medical Publishing Division: New York, 2001; pp 215-268.
30. Labetalol (Hydrochloride). In Therapeutic Drugs, Vol. 2; Dollery, C.; Boobis, A. R.; Burley, D.; Davies, D. M.; Davies, D. S.; Harrison, P. I.; Orme, M. L. E.; Park, B. K.; Goldberg, L. I., Eds.; Churchill Livingstone: Edinburgh, 1991; pp L1-L4.
31. Wagner, J. G.; Ganes, D. A.; Midha, K. K.; Gonzalez-Younes, I.; Sackellares, J. C.; Olson, L. D.; Affrime, M. B.; Patrick, J. E. Stepwise Determination of Multicompartment Disposition and Absorption Parameters from Extravascular Concentration-Time Data. Application to Mesoridazine, Flurbiprofen, Flunarizine, Labetalol, and Diazepam J. Pharmacokinet. Biopharm. 1991, 19, 413-455
32. Wu, C.-Y.; Benet, L. Z. Predicting Drug Disposition via Application of BCS: Transport/Absorption/Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System Pharm. Res. 2005, 22, 11-23
33. Product Information Trandate (labetalol hydrochloride) Tablets, FDA; http://www.accessdata.fda.gov/drugsatfda-docs/label/2010/018716s026lbl.pdf.
34. Draft Guidance on Labetalol Hydrochloride, FDA; http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM194633.pdf.
35. Yang, Y.; Faustino, P. J.; Volpe, D. A.; Ellison, C. D.; Lyon, R. C.; Yu, L. X. Biopharmaceutics Classification of Selected β-Blockers: Solubility and Permeability Class Membership Mol. Pharmaceutics 2007, 4, 608-614
36. Moss, A. M.; Endres, C. J.; Ruiz-Garcia, A.; Choi, D.-S.; Unadkat, J. D. Role of the Equilibrative and Concentrative Nucleoside Transporters in the Intestinal Absorption of the Nucleoside Drug, Ribavirin, in Wild-Type and Ent1(-/-) Mice Mol. Pharmaceutics 2012, 9, 2442-2449
37. Holmstock, N.; Annaert, P.; Augustijns, P. Boosting of HIV Protease Inhibitors by Ritonavir in the Intestine: The Relative Role of Cytochrome P450 and P-Glycoprotein Inhibition Based on Caco-2 Monolayers versus In Situ Intestinal Perfusion in Mice Drug Metab. Dispos. 2012, 40, 1473-1477
38. Holmstock, N.; Mols, R.; Annaert, P.; Augustijns, P. In Situ Intestinal Perfusion in Knockout Mice Demonstrates Inhibition of Intestinal P-Glycoprotein by Ritonavir Causing Increased Darunavir Absorption Drug Metab. Dispos. 2010, 38, 1407-1410
39. Escribano, E.; Sala, X. G.; Salamanca, J.; Navarro, C. R.; Regué, J. Q. Single-Pass Intestinal Perfusion to Establish the Intestinal Permeability of Model Drugs in Mouse Int. J. Pharm. 2012, 436, 472-477
40. a values) of Organic Compounds by Multiplexed Capillary Electrophoresis Using Aqueous and Cosolvent Buffers J. Pharm. Sci. 2008, 97, 2581-2606
41. a Values of β-Blockers by Automated Potentiometric Titrations J. Pharm. Biomed. Anal. 2000, 23, 459-468
42. Henchoz, Y.; Guillarme, D.; Martel, S.; Rudaz, S.; Veuthey, J.-L.; Carrupt, P.-A. Fast log P Determination by Ultra-High-Pressure Liquid Chromatography Coupled With UV and Mass Spectrometry Detections Anal. Bioanal. Chem. 2009, 394, 1919-1930
43. Burgot, G.; Serrand, P.; Burgot, J.-L. Thermodynamics of Partitioning in the n-Octanol/Water System of Some β-Blockers Int. J. Pharm. 1990, 63, 73-76
44. Abushammala, I.; Garrigues, T. M.; Casabó, V. G.; Nácher, A.; Martín-Villodre, A. Labetalol Absorption Kinetics: Rat Small Intestine and Colon Studies J. Pharm. Sci. 2006, 95, 1733-1741
45. Neuhoff, S.; Ungell, A.-L.; Zamora, I.; Artursson, P. pH-Dependent Bidirectional Transport of Weakly Basic Drugs Across Caco-2 Monolayers: Implications for Drug-Drug Interactions Pharm. Res. 2003, 20, 1141-1148
46. Lennernäs, H.; Palm, K.; Fagerholm, U.; Artursson, P. Comparison Between Active and Passive Drug Transport in Human Intestinal Epithelial (Caco-2) Cells in Vitro and Human Jejunum in Vivo Int. J. Pharm. 1996, 127, 103-107
47. Lee, K.-J.; Johnson, N.; Castelo, J.; Sinko, P. J.; Grass, G.; Holme, K.; Lee, Y.-H. Effect of Experimental pH on the in Vitro Permeability in Intact Rabbit Intestines and Caco-2 Monolayer Eur. J. Pharm. Sci. 2005, 25, 193-200
48. Custodio, J. M.; Wu, C.-Y.; Benet, L. Z. Predicting Drug Disposition, Absorption/Elimination/Transporter Interplay and the Role of Food on Drug Absorption Adv. Drug Delivery Rev. 2008, 60, 717-733
49. Cao, X.; Yu, L. X.; Barbaciru, C.; Landowski, C. P.; Shin, H.-C.; Gibbs, S.; Miller, H. A.; Amidon, G. L.; Sun, D. Permeability Dominates in Vivo Intestinal Absorption of P-gp Substrate With High Solubility and High Permeability Mol. Pharmaceutics 2005, 2, 329-340
50. Dahan, A.; Sabit, H.; Amidon, G. L. Multiple Efflux Pumps are Involved in the Transepithelial Transport of Colchicine: Combined Effect of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 Leads to Decreased Intestinal Absorption Throughout the Entire Small Intestine Drug Metab. Dispos. 2009, 37, 2028-2036
51. Valenzuela, B.; Nácher, A.; Ruiz-Carretero, P.; Martín-Villodre, A.; López-Carballo, G.; Barettino, D. Profile of P-Glycoprotein Distribution in the Rat and its Possible Influence on the Salbutamol Intestinal Absorption Process J. Pharm. Sci. 2004, 93, 1641-1648